5 units tirzepatide Dosing for Weight Loss in Lilly releases Zepbound® (tirzepatide) single-dose
Description
& Duffy, J
single incretin receptor activation
Originally prescribed to help with the management of other conditions, the FDA approved these medications for use in weight loss within the last several years
Additionally, individuals with allergies to GLP-1 receptor agonists should discuss potential risks
Notably, laboratory tests have limited (if any) value in the diagnosis
